hCG in Male Hypogonadism and Fertility Preservation

Human chorionic gonadotropin is a glycoprotein hormone with FDA-approved indications in male hypogonadism, cryptorchidism and ovulation induction. This guide covers its role in male endocrine and fertility management. Its separate and discredited use in weight-loss protocols is addressed in our hCG for weight loss guide.

This guide situates hCG within the broader field of peptide therapy and is written for clinicians. It is clinical education, not medical advice, and nothing here should be read as a treatment recommendation or protocol.

What hCG is and how it acts

hCG is a glycoprotein hormone produced in pregnancy by placental tissue. Structurally it closely resembles luteinizing hormone (LH), and it binds and activates the same receptor.

In men, the LH receptor sits on Leydig cells in the testis. Activating it drives testosterone production within the testis itself. Because hCG has a considerably longer half-life than LH, it provides a sustained stimulus from a less frequent injection.

This is the key pharmacologic point: hCG acts directly at the testis, bypassing the hypothalamus and pituitary entirely. That distinguishes it from agents such as gonadorelin or enclomiphene, which act upstream and depend on an intact pituitary response.

Why intratesticular testosterone matters

This is the concept most often missed, and it explains the entire fertility-preservation rationale.

Serum testosterone and intratesticular testosterone are not the same thing. Concentrations inside the testis are far higher than in blood — by a large multiple — and spermatogenesis requires that high local concentration. Normal serum levels are not sufficient.

When a man takes exogenous testosterone, serum levels rise and negative feedback suppresses LH and FSH. Without LH stimulating the Leydig cells, intratesticular testosterone collapses even though serum testosterone looks excellent. Spermatogenesis fails, and testicular volume falls.

This is why men on testosterone therapy become subfertile or infertile while their laboratory results appear optimal. The lab is measuring the wrong compartment. Adding hCG restores the LH signal at the Leydig cell, maintaining intratesticular testosterone and preserving spermatogenesis and testicular size during therapy.

Approved indications

hCG is FDA-approved in males for prepubertal cryptorchidism not due to anatomic obstruction, and for hypogonadotropic hypogonadism secondary to pituitary deficiency. In women it is approved for ovulation induction in selected anovulatory infertility, where it substitutes for the LH surge that triggers final oocyte maturation.

Its use alongside testosterone replacement therapy for testicular preservation is off-label, though it is well established in andrology and reproductive endocrinology practice and supported by a reasonable literature.

hCG has also been used as monotherapy in some hypogonadal men who wish to preserve fertility, stimulating endogenous production rather than replacing it.

Monitoring and practical considerations

Because hCG drives testosterone production, it also drives aromatization to estradiol, sometimes more than exogenous testosterone does at comparable serum levels. Estradiol warrants monitoring, and symptomatic elevation is a recognized issue.

Standard testosterone therapy monitoring applies: hematocrit, symptoms, and periodic reassessment. Where fertility is the objective, semen analysis is the endpoint that matters, not serum testosterone.

The important practical rule for any male patient starting testosterone: ask about fertility intentions first. The suppression is often reversible but recovery can take many months and is not guaranteed. A man who wants children in the future needs that conversation before the first injection, not after a year of therapy.

hCG is a prescription drug. Products marketed online as hCG for weight loss, including homeopathic preparations, are unregulated and separately problematic — and hCG is not effective for weight loss, a point the FDA requires approved labeling to state directly.